| Product Code: ETC12463379 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Imatinib Drug Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Imatinib Drug Market - Industry Life Cycle |
3.4 Jordan Imatinib Drug Market - Porter's Five Forces |
3.5 Jordan Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Jordan Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Jordan Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Jordan Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Jordan Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Jordan Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be treated using Imatinib in Jordan |
4.2.2 Growing healthcare infrastructure and investments in Jordan |
4.2.3 Rising awareness about the benefits of Imatinib therapy among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Jordan |
4.3.2 Competition from alternative treatments or therapies |
4.3.3 Pricing pressures and affordability issues for Imatinib in the Jordanian market |
5 Jordan Imatinib Drug Market Trends |
6 Jordan Imatinib Drug Market, By Types |
6.1 Jordan Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Jordan Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Jordan Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Jordan Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Jordan Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Jordan Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Jordan Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Jordan Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Jordan Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Jordan Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Jordan Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Jordan Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Jordan Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Jordan Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Jordan Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Jordan Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Jordan Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Jordan Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Jordan Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Jordan Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Jordan Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Jordan Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Jordan Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Jordan Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Jordan Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Jordan Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Jordan Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Jordan Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Jordan Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Jordan Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Jordan Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Jordan Imatinib Drug Market Import-Export Trade Statistics |
7.1 Jordan Imatinib Drug Market Export to Major Countries |
7.2 Jordan Imatinib Drug Market Imports from Major Countries |
8 Jordan Imatinib Drug Market Key Performance Indicators |
8.1 Number of clinical trials or research studies conducted on Imatinib in Jordan |
8.2 Percentage of healthcare providers trained or certified in prescribing and administering Imatinib |
8.3 Patient adherence rate to Imatinib therapy |
8.4 Number of partnerships or collaborations between pharmaceutical companies and healthcare institutions for Imatinib development |
8.5 Rate of adverse events or side effects reported related to the use of Imatinib |
9 Jordan Imatinib Drug Market - Opportunity Assessment |
9.1 Jordan Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Jordan Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Jordan Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Jordan Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Jordan Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Jordan Imatinib Drug Market - Competitive Landscape |
10.1 Jordan Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Jordan Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here